17 June 2024 

A promising experimental antibiotic that could treat gonorrhea is headed to the Food and Drug Administration for approval by early next year, its developer told Future Pulse.

Zoliflodacin was found to be as effective as the current combination of antibiotics used to treat gonorrhea in a Phase III clinical trial that enrolled more than 900 people in Belgium, the Netherlands, South Africa, Thailand and the United States. The Global Antibiotic Research & Development Partnership, a Geneva-based nonprofit, ran it.